India’s pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion
India’s pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion. India’s pharma industry is considered to be the world's third largest by volume and 14th in terms of value of production. With an extremely diversified product base covering […]
Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities
Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to currently available Vabysmo vials Vabysmo has demonstrated rapid and robust vision and anatomical improvements in neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO) The ready-to-use Vabysmo PFS is co-packaged with the […]
Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness
Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to currently available Vabysmo vials Vabysmo has demonstrated rapid and robust vision and anatomical improvements in neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO) The ready-to-use Vabysmo PFS is co-packaged with the […]
Drowning deaths decline globally but the most vulnerable remain at risk
13 December 2024 -- The World Health Organization (WHO) publishes its first-ever report on drowning prevention, which reveals a 38% drop in the global drowning death rate since 2000—a major global health achievement. However, the report notes that drowning remains a major public health issue with more than 30 people estimated to be drowning every […]
New WHO report reveals governments deprioritizing health spending
12 December 2024 -- The 2024 Global Heath Expenditure Report by the World Health Organization (WHO) shows that the average per capita government spending on health in all country income groups fell in 2022 from 2021 after a surge in the early pandemic years. The report entitled, “Global spending on health Emerging from the pandemic” […]
Over 1 in 5 adults worldwide has a genital herpes infection
Situation at a glance 11 December 2024 --- Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally - according to new estimates released today. At least 1 person each second – 42 million people annually - is estimated to […]
New and updated data for Roche's fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma
Long-term data confirm fixed-duration Columvi and Lunsumio achieve durable remissions beyond the end of treatment, with real-world data suggesting reduced treatment-related travel burden due to less frequent dosing First presentation of Lunsumio given subcutaneously showed non-inferiority to intravenous treatment with a consistent safety profile, potentially providing an additional outpatient option with a shorter administration time […]
Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash
Basel, 9 December 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has commenced a tender offer for all of the outstanding shares of common stock of Poseida Therapeutics, Inc. (Poseida) (NASDAQ: PSTX) at a price of $9.00 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain […]
WHO supports Democratic Republic of the Congo reinforce efforts to diagnose disease in remote area
06 December 2024, Kinshasa – World Health Organization (WHO) is deploying experts to support health authorities in the Democratic Republic of the Congo carry out further investigations to determine the cause of a yet undiagnosed disease that has been reported in Panzi, a locality in Kwango province in the southwest of the country. Laboratory tests […]
Oropouche virus disease - Region of the Americas
Situation at a glance Since the last Disease Outbreak News on this event was published on 23 August 2024, three additional countries and one territory (Ecuador, Guyana, Panama and Cayman Island) have reported confirmed Oropouche virus disease in the Region of the Americas in 2024. In addition, imported Oropouche cases have been reported from Canada, […]